Maijing Gene
- Total Funding$14.3 M
OverviewSuggest Edit
Maijing Gene (迈景基因) is a company that develops a gene detection technology. It specializes in the research, development, production, promotion, and sales of molecular diagnostic products.
| Type | Private | |
| Founded | 2015 | |
| Website | maijinggene.com |
Latest Updates
| Cybersecurity rating | A | More |
Maijing Gene Office Locations
Maijing Gene has an office in Menlo Park
Menlo Park, CA, US
1455 O'Brien Dr
Maijing Gene Financials and Metrics
Summary Metrics
Founding Date | 2015 |
Maijing Gene total Funding | $14.3 m |
Maijing Gene latest funding size | $14.31 m |
Time since last funding | 2 years ago |
Maijing Gene investors | Shenzhen Capital Group, CASH Capital, Great Wall Fund Management |
Maijing Gene's latest funding round in December 2019 was reported to be $14.3 m. In total, Maijing Gene has raised $14.3 m
Maijing Gene Cybersecurity Score
Maijing Gene Online and Social Media Presence
Maijing Gene's Trends
Maijing Gene Frequently Asked Questions
When was Maijing Gene founded?
Maijing Gene was founded in 2015.
Who are Maijing Gene competitors?
Competitors of Maijing Gene include Dyadic International, Jenthera Therapeutics and Kolon TissueGene.
Where are Maijing Gene offices?
Maijing Gene has an office in Menlo Park.
How many offices does Maijing Gene have?
Maijing Gene has 1 office.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies